All articles starting with N
16,460 articles
Nanoparticle aggregation in vivo
Nanoparticle aggregation in vivo is the clumping of nanoparticles once they enter blood or tissue fluid. High ionic strength and protein adsorption drive it, altering biodistribution, pharmacokinetics, and toxicity.
Nanoparticle albumin-bound technology
Nanoparticle albumin-bound (nab) technology is a drug delivery platform that binds poorly water-soluble drugs to human serum albumin; its first product was Abraxane, approved in 2005.
Nanoparticle biodistribution quantification
Nanoparticle biodistribution quantification measures where engineered nanoparticles distribute in a living body after administration, typically reported as percentage of injected dose; it is the analytical core of nanomedicine development.
Nanoparticle charge-dependent behavior
Nanoparticle charge-dependent behavior is how a nanocarrier's surface charge, measured as zeta potential, governs which serum proteins adsorb onto it, how readily cells take it up, and how toxic it is.
Nanoparticle crossing of the placental barrier
Nanoparticle crossing of the placental barrier is the translocation of particles 1–100 nm from maternal circulation into placental tissue or the fetus, with size the key determinant.
Nanoparticle margination
Nanoparticle margination is the drift of nanoparticles in flowing blood toward the vessel wall, where they can adhere to the endothelium and deliver drugs to target sites.
Nanoparticle shape-dependent uptake
Nanoparticle shape-dependent uptake is how cell uptake of nanoparticles depends on shape, from spheres and rods to disks and stars, driven largely by membrane bending energy.
Nanoparticle size-dependent biodistribution
Nanoparticle size-dependent biodistribution is the principle that nanoparticle size governs where particles travel in the body, with particles under 5-6 nm cleared by the kidneys.
Nanoparticle stiffness-dependent behavior
Nanoparticle stiffness-dependent behavior is how a nanoparticle's mechanical rigidity, rather than its size or surface chemistry, shapes circulation, immune clearance, tumor delivery, and cellular uptake.
Nanoparticle surfactants
Nanoparticle surfactants are surface-active agents built from solid colloidal particles, either bare particles or polar nanoparticle heads with hydrophobic polymer tails, that stabilize emulsions and foams.
Nanoparticle tracking analysis
Nanoparticle tracking analysis (NTA), also called particle tracking analysis, is a light-scattering microscopy technique that determines the size distribution and concentration of nanoparticles in liquid by tracking their Brownian motion.
Nanoparticle-based CAR-T cell engineering
Nanoparticle-based CAR-T cell engineering is a non-viral approach in which lipid nanoparticles deliver CAR genetic material to T cells inside the patient, bypassing the cost and delays of laboratory cell manufacturing.
Nanoparticle-cell membrane interaction
Nanoparticle-cell membrane interaction is the set of physical and biological processes by which nanoscale particles adhere to cell membranes and enter cells, mainly via endocytosis, and determines whether engineered drug carriers reach their target.
Nanoparticle-on-mirror nanocavity
A nanoparticle-on-mirror (NPoM) nanocavity is a plasmonic structure where a metallic nanoparticle sits on a metal film separated by a nanometer spacer, confining light into the gap for single-molecule spectroscopy, sensing, and room-temperature cavity quantum electrodynamics.
Nanophononic metamaterial
A nanophononic metamaterial (NPM) is a nanostructured material, typically a thin membrane with nanopillar resonators, that reduces thermal conductivity without degrading electrical properties, developed for thermoelectrics.
NanoPhoria
NanoPhoria, legally NanoPhoria s.r.l., is a Milan-based biotechnology company founded in 2022 as a spin-off from Italy's National Research Council; its lead asset, NP-MP1, targets heart failure.
NanoPhoria Bioscience
NanoPhoria Bioscience is a Milan-based biotechnology company founded in 2022 as a spin-off from Italy's National Research Council, developing an inhaled nano-in-micro drug delivery platform for heart failure.
Nanophotonic electron accelerator
A nanophotonic electron accelerator, also called dielectric laser acceleration, is a chip-scale accelerator in which laser pulses drive fields in a dielectric nanostructure to accelerate electrons.
Nanophotonic refractive-index biosensors
Nanophotonic refractive-index biosensors are optical sensors using subwavelength structures that confine light at a surface, so biomolecule binding shifts an optical resonance, enabling label-free, real-time detection.
Nanophotonic trapping and cooling of nanoparticles
Nanophotonic trapping and cooling of nanoparticles uses light fields shaped by chip-scale devices, including plasmonic nanostructures and waveguides, to trap nanoparticles and cool their motion toward the quantum regime.
Nanophotonic trapping of single atoms
Nanophotonic trapping of single atoms confines individual neutral atoms within a few hundred nanometers of chip-scale structures such as photonic-crystal waveguides, enabling strong atom–photon interfaces for quantum networks.
Nanopore protein sequencing
Nanopore protein sequencing is a proposed single-molecule technique that reads a protein's amino acid sequence by threading it through a nanometre-sized pore and decoding current disruptions.
Nanopore sequencing
Nanopore sequencing is a DNA and RNA sequencing method that ratchets single strands through protein pores and reads ionic-current changes in real time, enabling portable, long-read sequencing.
Nanoporous graphene
Nanoporous graphene (NPG) is a one-atom-thick sheet of graphene perforated with engineered nanometer-scale pores, so it acts as a selective membrane studied most extensively for desalination.
nanoPOTS
nanoPOTS (Nanodroplet Processing in One pot for Trace Samples) is a nanoliter-scale sample preparation method for proteomics, introduced in 2018 for single cells and tiny tissue samples.
Nanoprecipitation
Nanoprecipitation, also known as solvent displacement or antisolvent precipitation, is a one-step method for preparing polymeric nanoparticles, typically 100–300 nm, used to encapsulate hydrophobic drugs.
Nanoramic Laboratories
Nanoramic Laboratories, formerly FastCAP Systems, is an American energy storage company spun out of MIT in 2009 by CEO John Cooley and based in Woburn, Massachusetts, known for its Neocarbonix battery electrode technology.
Nanoramic, Inc.
Nanoramic, Inc. is a Woburn, Massachusetts energy-storage company founded out of MIT in 2009 by CEO John Cooley, known for its Neocarbonix electrode technology for lithium-ion batteries.
Nanorobotics
Nanorobotics is the engineering field that designs and operates nanorobots, molecular machines 1 to 1000 nm in size, chiefly for drug delivery, biosensing, and surgery.
Nanoscale
Nanoscale (journal), ISSN 2040-3364/2040-3372, a peer-reviewed RSC journal launched in 2009 with NCNST Beijing, publishing nanoscience and nanotechnology research weekly; hybrid model, 2025 Impact Factor 5.2.